For example, tirzepatide, a dual GLP-1 and GIP agonist, is FDA-approved under the brand name Zepbound specifically for chronic weight management in adults with obesity or overweight and at least one weight-related condition
By measuring IGF-1 during treatment, the doctor can tell if the sermorelin dose is sufficient (IGF-1 should rise into a target range) or if adjustments are needed
During your visit, well review your health history, lifestyle habits, and weight loss goals to determine if GLP-1 treatment is the right fit for you
Merely attributing spleen deficiency syndrome to a decline in the immune organ index is overly simplistic
Additionally, GLP-1RA improves BMI, SBP, HbA1c, LDL-C, and CRP levels